You have to give props to Sundial Growers (NASDAQ:SNDL) and Tilray (NASDAQ:TLRY) for their impressive share-price gains so far this year. Both Canadian pot stocks captured the attention of online communities and rode the wave to become huge winners…
But if I had to pick between these stocks right now, it would be an easy choice. I’d go with Trulieve without a moment’s hesitation. Here are three ways Trulieve trounces both Sundial and Tilray.
1. Sales growth
One of the best ways to determine how well a cannabis producer is performing is to check out its sales growth. On this front, there’s basically no comparison between Trulieve and either Sundial or Tilray.
Sundial’s net revenue from cannabis fell 29% year over year in the first quarter of 2020 to 9.9 million Canadian dollars (around $8.2 million). The good news for the company was that it generated interest and investment revenue totaling CA$15.7 million (roughly $13 million).
Tilray reported total revenue of $56.6 million in Q4 (the most recent quarter before its merger with Aphria), up 20.5% year over year. Aphria’s net revenue rose 6.4% year over year in its fiscal third quarter to CA$153.6 million (in the ballpark of $127 million).
Meanwhile, Trulieve’s revenue more than doubled year over year in Q1 to $193.8 million. Most of this growth stemmed from organic expansion in the company’s home state of Florida. Trulieve’s revenue jumped 15% from the previous quarter, better than the year-over-year cannabis revenue growth for Sundial and Aphria and not much lower than the growth for Tilray.
Sundial surprised investors in Q1 with positive adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA). However, the Canadian company still posted a huge net loss of CA$134.4 million.
Tilray also achieved positive adjusted EBITDA in its latest quarterly results. Like Sundial, though, the company remained unprofitable, with a net loss of $3 million. Aphria was…
Continue reading at THE MOTLEY FOOL